Neurocognitive and Psychological Outcomes among Children and Adolescents with Brain Tumors: Development of an Observational and Longitudinal Prospective Study Protocol.
central nervous system tumors
child development
neuropsychological outcomes
pediatric brain tumors
pediatric oncology
Journal
Behavioral sciences (Basel, Switzerland)
ISSN: 2076-328X
Titre abrégé: Behav Sci (Basel)
Pays: Switzerland
ID NLM: 101576826
Informations de publication
Date de publication:
27 Jun 2023
27 Jun 2023
Historique:
received:
27
04
2023
revised:
08
06
2023
accepted:
24
06
2023
medline:
28
7
2023
pubmed:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
Children and adolescents affected by brain tumors are at risk for neuropsychological sequelae that need to be evaluated in order to plan adequate rehabilitation programs, and to support their development and recovery. This work aims to describe an innovative prospective observational study protocol for the early evaluation and monitoring over time of neuropsychological outcomes in this pediatric population. Pediatric patients aged 3-17 with a brain tumor diagnosis will be assessed through the use of a battery of Italian standardized neuropsychological tests, with good psychometric properties and age-appropiate, at three different time points of their clinical course: at diagnosis and before surgery (T0), after surgical removal and before the start of potential adjuvant therapies (T1), and at the one-year follow-up after potential adjuvant therapies (T2). This study will allow clinicians to support the neuropsychological development of these children by promoting appropriate and timely rehabilitation and educational programs from the early phases of their clinical course.
Identifiants
pubmed: 37503983
pii: bs13070536
doi: 10.3390/bs13070536
pmc: PMC10376337
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Expert Rev Pharmacoecon Outcomes Res. 2005 Dec;5(6):705-19
pubmed: 19807613
Dev Med Child Neurol. 2013 May;55(5):408-17
pubmed: 23157447
Pediatr Rehabil. 2004 Jan-Mar;7(1):1-14; discussion 15-6
pubmed: 14744668
Bioengineering (Basel). 2018 Sep 11;5(3):
pubmed: 30208602
Childs Nerv Syst. 2020 Jun;36(6):1145-1151
pubmed: 31177321
PM R. 2010 Dec;2(12 Suppl 2):S306-12
pubmed: 21172692
Pediatr Neurol. 2012 Jun;46(6):339-44
pubmed: 22633627
Cad Saude Publica. 2013 Jan;29(1):13-28
pubmed: 23370021
Children (Basel). 2023 Feb 27;10(3):
pubmed: 36980030
J Clin Oncol. 2021 Jun 1;39(16):1718-1726
pubmed: 33886348
Dev Neurosci. 2006;28(4-5):244-55
pubmed: 16943648
Ann Intern Med. 2007 Oct 16;147(8):W163-94
pubmed: 17938389
Brain. 1998 Apr;121 ( Pt 4):561-79
pubmed: 9577385
Pediatr Blood Cancer. 2020 Sep;67(9):e28538
pubmed: 32652734
Neuropsychology. 2009 Mar;23(2):255-64
pubmed: 19254098
Pediatr Blood Cancer. 2012 Sep;59(3):536-9
pubmed: 22555997
Arch Pediatr Adolesc Med. 2007 Aug;161(8):798-806
pubmed: 17679663
J Pediatr Rehabil Med. 2011;4(1):47-58
pubmed: 21757810
Pediatr Blood Cancer. 2010 Sep;55(3):525-31
pubmed: 20658625
Lancet Oncol. 2004 Jul;5(7):399-408
pubmed: 15231246
Pediatr Blood Cancer. 2016 Feb;63(2):191-5
pubmed: 26451963
Neuroimage Clin. 2019;23:101886
pubmed: 31254938
Neuro Oncol. 2011 May;13(5):517-24
pubmed: 21372071
Neuro Oncol. 2012 Nov;14 Suppl 5:v1-49
pubmed: 23095881
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Brain Inj. 2020 Mar 20;34(4):583-590
pubmed: 32050813
Clin Neuropsychol. 2017 Feb;31(2):307-328
pubmed: 27705087
Pediatrics. 2006 Apr;117(4):1372-81
pubmed: 16585335
Qual Life Res. 2016 Feb;25(2):435-446
pubmed: 26289022
Pediatr Blood Cancer. 2015 Dec;62 Suppl 5:S460-513
pubmed: 26700917
Cogn Affect Behav Neurosci. 2006 Mar;6(1):9-17
pubmed: 16869225